Serum Institute of India Gets CDSCO Panel Nod To Conduct Phase II/III CT of Typhoid Conjugate Vaccine Bivalent Dr. Divya Colin15 Jan 2025 6:00 PM ISTNew Delhi: Noting the phase I clinical trial report presented by the vaccine major Serum Institute of India, the Subject Expert Committee (SEC)...
Single dose typhoid conjugate vaccine provides lasting efficacy in children Dr. Kamal Kant Kohli31 Jan 2024 10:30 AM ISTA single dose of the typhoid conjugate vaccine, Typbar TCV, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12...
Revise Phase IV CT Protocol: CDSCO panel tells Zydus Lifesciences on Typhoid Vi Conjugate Vaccine with Yellow Fever Vaccine Dr. Divya Colin15 April 2023 5:15 PM ISTNew Delhi: In response to the drug major Zydus Life Sciences' proposal to conduct Phase IV clinical for Typhoid Vi Conjugate Vaccine I.P.(TCV) with...
Biological E Typhoid Conjugate Vaccine gets WHO pre-qualification MD Bureau12 Dec 2020 1:00 PM ISTBE's TCV is a single-dose injectable vaccine, which can be administered to children from six months of age to adults up to the age of 45 and it is...
